page
Home2
About2
Info2
Videos2
FAQ2
Contact3
Supplements2
Account2

 

Prelox® Natural Sex for Men® (60 Tablets)

$40.00
Price: $40.00

Prelox® Natural Sex for Men®

 

The health of the vascular system is overlooked in the effort to support sexual function in aging men. Blood flow through the delicate lining of the arteries (the endothelium) is essential to sexual arousal. So it should come as no surprise that endothelial function is closely associated with male sexual capacity.27

Life Extension has discovered supportive clinical research for a scientifically validated, natural dietary supplement formula to promote endothelial function and blood flow to the place men need it most — for maximum performance.

The ingredients found in Prelox® Natural Sex for Men® have yielded compelling and highly satisfactory results in five independent clinical studies.28-32

Our analysis also confirms that unlike some performance enhancement supplements marketed as "natural," Prelox® Natural Sex for Men® is not adulterated with prescription drugs.

The patented blend of the following natural ingredients positively affects the male physiology in these three ways, to provide optimal support:

  1. Pycnogenol® (standardized French maritime pine bark extract) activates endothelial nitric oxide synthase (eNO-S),33 the enzyme required to make nitric oxide. Nitric oxide (NO) relaxes the vessels that enable efficient blood flow — the key to healthy male sexual activity and overall vascular health. Pycnogenol® further amplifies this relaxing effect by extending the amount of time nitric oxide remains in the bloodstream.
  2. L-Arginine is the biological precursor to nitric oxide synthesis in the endothelium.33 It interacts synergistically with Pycnogenol® to sustain nitric oxide levels sufficient for healthy sexual function.
  3. Icariin, a natural plant compound used in traditional Chinese medicine, has been shown to deactivate the enzyme normally responsible for winding down male sexual response, further promoting sustained activity.34

1. Cell. 2006 Dec 15;127(6):1109-22.
2. Endocrinology. 2008 Jan;149(1):84-92.
3. Food Chem Toxicol. 2008 Apr;46(4):1320-6
4. Mol Nutr Food Res. 2008 Jun;52 Suppl 1:S62-70.
5. Cytokine. 2009 Aug;47(2):137-42
6. Nutr Cancer. 1999;35(1):80-6.
7. Anticancer Agents Med Chem. 2006 Sep;6(5):389-406.
8. Nature. 2006 Nov 16;444(7117):337-42.
9. Nature. 2004 Aug 5;430(7000):686-9.
10. Xenobiotica. 2000 Sep;30(9):857-66
11. Genes Nutr (2009) 4:297–307
12. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16568-73.
13. Brain Res. 2007 Oct 10;1173:117-25.
14. J Natl Cancer Inst. 1997 May 21;89(10):718-23.
15. Int J Obes Relat Metab Disord. 1998 Mar;22(3):227-9.
16. Planta Med. 2008 Oct;74(13):1656-65.
17. J Steroid Biochem Mol Biol. 2008 May;110(1-2):176-85
18. Int J Cancer. 2004 Sep 1;111(3):440-3.
19. Altern Med Rev. 2002 Apr;7(2):112-29.
20. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1953-60.
21. Postepy Hig Med Dosw (Online). 2008 Sep 5;62:451-62.
22. Postepy Hig Med Dosw (Online). 2008 Sep 5;62:451-62.
23. Cancer Detect Prev. 1997;21(2):178-90.
24. Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):543-59.
25. Neurology. 2004 Dec 28;63(12):2240-4.
26. Int J Clin Pharmacol Ther. 2000 Sep;38(9):430-5.
27. Int J Impot Res 2008 Dec; Suppl 2:S9-14.
28. Int J Impot Res. 2008 Mar;20(2):173-80.
29. Phytother Res. 2009 Mar;23(3):297-302.
30. J Sex Marital Ther. 2003 May;29(3):207-13.
31. European Bulletin of Drug Research. 2005;13(1): 7–13.
32. Akush Ginekol (Sofiia). 2007;46(5):7-12.
33. Rohdewald P. Pycnogenol, French maritime pine bark extract. In: Coates P, ed. Encyclopedia of Dietary Supplements. New York; Marcel Dekker; 2004.
34. Urology. 2006 Dec;68(6):1350-4.
35. J Sex Med. 2010;7(4):1598-1607.
36. J Alt Complement Med. 1998;4(3):289-303.
37. Menopause. 2008 Nov-Dec;15(6):1157-62.
38. Phtyother Res. 2011;doi:10.1002/ptr.3597.
39. Altern Med Rev. 2001 Apr;6(2):207-9.
40. Biofactors. 2004;21(1-4):127-31.
41. Infl amm Res. 1996 Nov;45(11):546-9.
42. Indian J Exp Biol. 1999 Feb;37(2):124-30.
43. Carcinogenesis. 1995 Sep;16(9):2057-62.
44. Biol Pharm Bull. 2002 Sep;25(9):1197-202.
45. Curr Cancer Drug Targets. 2008 Nov;8(7):634-46.
46. Cancer Lett. 2009 Sep 8;282(1):48-54. Epub 2009 Apr 1.
47. Indian J Exp Biol. 2009 May;47(5):355-60.
48. J Neuroinflammation. 2010 Jan 14;7:3.
49. Inflammation. 2010 Nov 13. [Epub ahead of print]
50. Exp Biol Med. 2004 Mar;229(3):247-54.
51. Chem Biodivers. 2010 Jul;7(7):1835-40.
52. Oncol Rep. 2007 Jun;17(6):1525-31.
53. Plant Foods Hum Nutr. 2010 Jun;65(2):158-63.
54. Crit Rev Food Sci Nutr. 2011 Dec;51(10):946-54.
55. Food Chem Toxicol. 2001 Feb;39(2):109-17.
56. Mutat Res. 2010 Oct 13;692(1-2):6-11.
57. Biol Pharm Bull. 2001 Oct;24(10):1206-9.
58. Int J Biomed Sci. 2011;7(2):101-111.
59. Artery. 1995; 21(6):312-6.
60. Hepatol Res. 2006 Mar;34(3):199-206;
61. World J Gastroenterol. 2003 Apr;9(4):791-4.
62. Biochem Pharmacol. 1994 Aug 3;48(3):621-4.
63. Alcohol. 1999 Feb; 17(2):163-8.
64. Fiziol Zh. 1996; 42(1-2):65-72.
65. Neuroreport. 1999 Jan 3;10(8):1799-801.
66. Biochim Biophys Acta. 2000 Sep 27;1487(2-3):113-27.
67. Biochim Biophys Acta. 2004 May 3;1672(2):100-11.
68. Z Naturforsch [C]. 2007 Mar-Apr;62(3-4):215-22.
69. Turk J Gastroenterol. 2008 Jun;19(2):92-8.
70. Chem Biol Interact. 2008 Dec 24. [Epub ahead of print]
71. World J Gastroenterol. 2008 Dec 14;14(46):7101-6.
72. Curr Pharm Biotechnol. 2009 Sep;10(6):641-9.
73. Indian J Exp Biol. 2010 Mar;48(3):323-8.
74. Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):32-41.
75. Eur J Pharmacol. 2008 Sep 28;593(1-3):105-11.
76. Toxicology. 2004 Mar 1;196(1-2):117-25.
77. J Biol Chem. 2002 Feb 1;277(5):3456-63.
78. Proc Natl Acad Sci USA. 1993 Sep 1;90(17):7915-22.
79. Science. 1997 Oct 17;278(5337):407-11.
80. Hum Genet. 1996 Mar;97(3):319-23.
81. Cancer Sci. 2004 Apr;95(4):290-9.
82. Carcinogenesis. 1995 Apr;16(4):861-7.
83. Proc Natl Acad Sci USA. 1990 Oct;87(19):7777-81.
84. Environ Mol Mutagen. 1997, 30(4): 468-74.
85. Environ Mol Mutagen. 1996, 27(3): 211-8.
86. Toxicology. 2000;155(1-3):63-71.
87. Mutat Res. 2003 Feb-Mar;523-524:209-16.
88. Can J Anim Sci 1997, 77: 4, 715-721
89. J Nutraceut Funct Med Foods. 2000, 2: 3, 5-23
90. J Exp Biol 2001 204:443-455.
91. Zhongguo Zhong Yao Za Zhi. 2001 Oct;26(10):699-702.
92. Evid Based Complement Alternat Med. 2011;2011:534069.
93. Acta Biochim Pol. 2006;53(2):395-7.
94. J Invest Dermatol. 2001 Aug;117(2):309-17.
95. Arerugi. 2010 Jun;59(6):706-15.
96. Dermatitis. 2007 Jun;18(2):82-91.
97. J Invest Dermatol. 2005 Mar;124(3):587-95.
98. The Physiology and Pathophysiology of the Skin. London: Academic Press; 1980:2147-55.
99. Sleep Med Rev. 2005 Oct;9(5):355-64.
100. Curr Opin Pulm Med. 2005 Nov;11(6):481-4.
101. Nat Rev Neurosci. 2009;10(3):199-210.
102. Obes Rev. 2009 Nov;10 Suppl 2:37-45.
103. BMC Public Health. 2007 Jun 28;7:129.
104. Science. 2010 Dec 3;330(6009):1349-54.
105. J Clin Sleep Med. 2007 Dec 15;3(7):681-8.
106. Obesity (Silver Spring). 2009 Apr;17(4):767-71.
107. Int J Obes (Lond). 2009 Jan;33(1):46-53.
108. Am J Physiol. 1996 Aug;271(2 Pt 1):E261-70.
109. Am J Hypertens. 2010 Dec;23(12):1286-91.
110. Lakartidningen. 2002 Jan 17;99(3):154-7.
111. Occup Med (Lond). 2010 Jan;60(1):10-20.
112. Chronobiol Int. 2011 Feb;28(1):76-80.
113. Lipids Health Dis. 2010 Oct 30;9:125.
114. Prog Cardiovasc Dis. 2009 Jan-Feb;51(4):294-302.
115. Prog Cardiovasc Nurs. 2004 Spring;19(2):56-9.
116. Sleep. 2010 Aug 1;33(8):1037-42.
117. Sleep. 2009 Mar 1;32(3):295-301.
118. J Sleep Res. 1997 Sep;6(3):179-88.
119. Psychiatry Clin Neurosci. 2003 Jun;57(3):265-70.
120. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, PA: WB Saunders; 2000:1140-57.
121. The Open Sleep Journal 2009, 2, 26-32
122. Eur J Nutr. 2005 Mar;44(2):128-32.
123. Hypertens Res. 2011 Sep;34(9):1035-40.
124. Eur J Clin Nutr. 2007 Apr;61(4):536-41.
125. So Ken Study: Effect of Lactium® on sleep disorders. October, 2006.
126. BMC Med. 2010 Aug 16;8:51.
127. Skin Pharmacol Appl Skin Physiol. 2002;15(5):374-80.
128. J Surg Res. 2008;144(1):94-101.
129. J Ethnopharmacol. 2010 Oct 28;132(1):109-14.
130. J Cosmet Sci. 2009;60(4):395-403.
131. JANA. 2008;11(1):50-6.
132. J Nutr. 2003 Nov;133(11 Suppl 1):3778S-3784S.
133. Anticancer Res. 1999 Sep-Oct;19(5A):3681-3.
134. Anticancer Res. 1995 Nov-Dec;15(6B):2479-87.
135. Carcinogenesis. 1989 Sep;10(9):1595-8.
136. Life Sci. 1997;61(4):343-54.
137. Biosci Biotechnol Biochem. 2007 Apr;71(4):916-25
138. J Nutr Sci Vitaminol (Tokyo). 2006 Dec;52(6):457-66.
139. Altern Ther Health Med. 2001 May-Jun;7(3):79-91.
140. Glycoconj J. 1994 Dec;11(6):527-32.
141. J Natl Cancer Inst. 1992 Mar 18;84(6):438-42.
142. Paper presented at: International Conference on Diet and Prevention of Cancer; May 1999; Tampere, Finland.
143. Prostate Cancer Prostatic Dis. 2003;6(4):301-4.
144. J Natl Cancer Inst. 2002 Dec 18;94(24):1854-62.
145.  Neoplasia. 2007 Aug;9(8):662-70.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

 

 

© 2014
Arthritis Center of Riverside
11725 Slate Avenue
Riverside, CA  92505
Tel: 951.352.1700
Fax: 951.352.9117

Website Tags  Website Index  Logout

 

     *The information in this website is not intended to replace a rheumatology textbook nor be a complete update of the rheumatology scientific literature.  It should not be misconstrued as personal medical advice.  Rather, it portrays Dr. Al Robert Franco's interests in the field of rheumatology, namely, the interrelationship between infections and rheumatic diseases and how this applies to the treatment of arthritis.